CVE-2020-37094

CVE-2020-37094 is a high-severity vulnerability in Espocrm with a CVSS 3.x base score of 8.1. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-303.

Key facts

Description

EspoCRM 5.7.0 prior to 5.9.0 contains an authentication token reuse vulnerability that allows authenticated attackers to bypass two-factor authentication by exploiting token-to-password-hash mapping in application/Espo/Core/Utils/Authentication/Espo.php. Attackers can obtain an authentication token for a controlled account and replay it against any victim account sharing the same password, since tokens are bound to password hashes rather than unique per-user values, bypassing the victim's 2FA protections.

Frequently asked questions

What is CVE-2020-37094?
EspoCRM 5.7.0 prior to 5.9.0 contains an authentication token reuse vulnerability that allows authenticated attackers to bypass two-factor authentication by exploiting token-to-password-hash mapping in application/Espo/Core/Utils/Authentication/Espo.php. Attackers can obtain an authentication token for a controlled account and replay it against any victim account sharing the same password, since tokens are bound to password hashes rather than unique per-user values, bypassing the victim's 2FA protections.
How severe is CVE-2020-37094?
CVE-2020-37094 has a CVSS 3.x base score of 8.1, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability none.
Is CVE-2020-37094 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (38th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2020-37094?
CVE-2020-37094 affects Espocrm. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2020-37094?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
Does CVE-2020-37094 have an EU (EUVD) identifier?
Yes. CVE-2020-37094 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2020-31008.
When was CVE-2020-37094 published?
CVE-2020-37094 was published on 2026-02-03 and last updated on 2026-07-15.

References

EU advisories (EUVD)

Affected products (1)

More vulnerabilities in Espocrm

All CVEs affecting Espocrm →

Other CWE-303 vulnerabilities

Browse all CWE-303 vulnerabilities →